Inactive Instrument

Integrated BioPharma, Inc. Stock Other OTC

Equities

INBP

US45811V1052

Pharmaceuticals

Sales 2022 56.25M Sales 2023 50.67M Capitalization 9.92M
Net income 2022 3M Net income 2023 - EV / Sales 2022 0.3 x
Net Debt 2022 1.71M Net Debt 2023 1.36M EV / Sales 2023 0.22 x
P/E ratio 2022
4.17 x
P/E ratio 2023
-292 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 20.22%
More Fundamentals * Assessed data
Dynamic Chart
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Integrated BioPharma, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2023 CI
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Integrated BioPharma, Inc. Announces the Death of Edward G. Kay, Executive Chairman and President CI
Integrated BioPharma, Inc. Enters into Fourth Amendment to Revolving Credit, Term Loan and Security Agreement CI
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Integrated Biopharma, Inc. Announces Change in Directors CI
Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q1 Revenue $15.6M MT
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022 CI
Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q4 Revenue $14.6M MT
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021 CI
More news
Managers TitleAgeSince
Chief Executive Officer 57 91-04-30
Chief Executive Officer 54 94-11-30
Director of Finance/CFO 63 05-11-16
Members of the board TitleAgeSince
Chief Executive Officer 54 94-11-30
Director/Board Member 56 22-06-19
Director/Board Member 76 20-11-03
More insiders
Integrated Biopharma Inc. is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements, and herbal products. The Company’s business segments include Contract Manufacturing operated by Manhattan Drug Company, Inc. (MDC), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers; and Other Nutraceutical Businesses, which includes the operations of AgroLabs, Inc. (AgroLabs), The Vitamin Factory (the Vitamin Factory), IHT Health Products, Inc. (IHT), MDC Warehousing and Distribution, Inc., and Chem International, Inc. AgroLabs distributes healthful nutritional products for sale through mass market, grocery and drug and vitamin retailers under the brands: Peaceful Sleep, and Wheatgrass and other products. IHT is a distributor of fine natural botanicals, including multi-minerals produced under a license agreement. Chem is a distributor of raw materials.
More about the company